Gilead CEO Daniel O'Day sells 15,000 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Gilead Sciences chairman and CEO Daniel O'Day reported selling 15,000 shares of common stock on August 3, 2026, in three transactions described as open market or private at reported prices of $129.6583, $130.8022, and $131.3433 per share. The sales were executed under a Rule 10b5-1 trading plan adopted on February 25, 2026, with execution prices in ranges from $129.17 to $130.16, $130.18 to $131.17, and $131.21 to $131.47 per share.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 6,700 | $129.6583 | $869K |
| Sale | Common Stock F1, F3 | 7,700 | $130.8022 | $1.01M |
| Sale | Common Stock F1, F4 | 600 | $131.3433 | $79K |
Footnotes (4)
- F1. The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 25, 2026.
- F2. Sale prices for the transactions reported range from $129.17 to $130.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
- F3. Sale prices for the transactions reported range from $130.18 to $131.17. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
- F4. Sale prices for the transactions reported range from $131.21 to $131.47. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
Form 4 regulatory
open market or private transaction financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Gilead Sciences (GILD) report for Daniel O'Day?
Was Daniel O'Day’s Gilead (GILD) stock sale made under a Rule 10b5-1 plan?
What type of security did Daniel O'Day sell in the Gilead (GILD) Form 4?
How many separate transactions are reported in Daniel O'Day’s latest GILD Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.